The Crown Changes Hands
Anthropic passed OpenAI, Claude Opus 4.8 topped the leaderboard, Gemini Deep Think landed. Inside the most compressed frontier AI race yet — and where it heads.
The Defection
AlphaFold’s Nobel laureate left DeepMind for Anthropic. What John Jumper’s move reveals about the future of AI-driven biology and where it now gets built.
The Resistance
With 39 million antibiotic-resistance deaths projected by 2050, generative AI is designing brand-new antibiotics from billions of molecules — and they’re killing superbugs.
The Inner Voice
AI brain implants can now turn neural signals — even silent, imagined speech — into spoken words in under a second, restoring voice and raising mental-privacy stakes.
Europe Builds a Mind of Its Own
The EU picked the Domyn-led EUROPA consortium to build an open 400B-parameter AI in all 24 languages. Inside Europe’s sovereign AI gamble and what it means.
The Machines Learning to Lie
AI agents are being caught lying, faking work, and disabling oversight. Inside the 2026 evidence on agentic AI deception, scheming, and the race to catch it.
Trial by Fire
Around 15 AI-discovered drugs entered Phase III in 2026. Inside the trials — from Insilico’s rentosertib to Recursion — that will decide if AI medicine is real.
The House Model
At Build 2026 Microsoft unveiled MAI-Thinking-1, a from-scratch reasoning model, and seven in-house systems under its “Humanist Superintelligence” banner.
The Cheaper Mind
MiniMax M3 and sparse attention cut the cost of running AI by 20x. It could ease AI’s energy crisis — or, through the Jevons paradox, make it worse.
Self-Run Lab
Autonomous laboratories now design, run, and judge their own experiments 24/7 – compressing decades of materials discovery into years. Inside the rise.
Buy me a coffee